CSI Market
Sign In | Register

Aspire Biopharma Holdings Inc (ASBP) Annual Balance Sheets

Annual · GAAP · USD millions
Access ASBP quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Aspire Biopharma Holdings Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent1.00
Cash & Short-term Investments1.00
Other Receivables0.00
Inventories0.25
Prepaid Expense And Other Assets Current0.06
Total Current Assets1.31
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Total Assets1.31
Liabilities
Accounts Payable, Current AC1.01
Accrued Liabilities, Current AC1.01
Derivative Liability, Current DE0.04
Loans Payable, Current NO1.38
Other Liabilities, Current4.14
Total Current Liabilities7.59
Total Long-term Debt0.00
Other liabilities, Noncurrent0.10
ForwardPurchaseAgreementLiability0.10
Promissory Note Fee1.50
Total Liabilities7.69
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock20.88
Retained Earnings / Accumulated Deficit-27.26
Other Equity0.00
Common Stockholder's Equity-6.38
Non-controlling interests & other0.00
Total Stockholder's Equity-6.38
Liabilities & Stockholder's Equity1.31
4 historic quarters locked

Sign in to unlock the full Aspire Biopharma Holdings Inc balance sheet history.

Sign In Create Free Account

About Aspire Biopharma Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 30, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013682

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.